Innovating Works

PRONTO

Desconocido
MOODSTRATIFICATION: Immune Signatures for Therapy Stratification in Major Mood Disorders PRONTO DIAGNOSTICS LTD participó en un H2020: H2020-SC1-2016-2017 Objective: MOODSTRATIFICATION brings together 11 partners (psychiatrists, immunologists, epidemiologists, industry) from 7 countries stratif...
2017-12-05 - 2023-06-30 | Financiado
5-FU PGX: Prevalence of various genetic and epigenetic changes in genes associated with the anti cancer drug 5... PRONTO DIAGNOSTICS LTD tramitó un FP7: 5-Fluorouracil (5-FU) has been one of the most commonly used drugs in the treatment of various types of cancer (in particular, colorectal an...
Financiado
EUROTRAPS: Natural course pathophysiology models for early diagnosis prevention and innovative treatment of... PRONTO DIAGNOSTICS LTD participó en un FP7: The TNF Receptor Associated Syndrome (TRAPS) is a rare disease of innate immunity, caused by mutations in TNFR1. It is characterised by recu...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.